*This article is an automatic translation of the original article, provided here for your convenience. Read the original article. – Conc. conc. dec. no. 07-D-39 of 23 November 2007 relating to practices implemented in the passenger rail transport sector on the Paris-London route The Competition Council was again given the opportunity to refine its predatory pricing methodology. After the GlaxoSmithKline case (Cons. conc., Dec. No. 07-D-09 of 14 March 2007 relating to practices implemented by the laboratory GlaxoSmithKline France, chron. Concurrences n° 2-2007), in which a pharmaceutical company had been fined EUR 10 million for hindering the market entry of generic medicines competing with its own through predatory pricing practices, the Competition Council in the case commented on
Access to this article is restricted to subscribers
Already Subscribed? Sign-in
Access to this article is restricted to subscribers.
Read one article for free
Sign-up to read this article for free and discover our services.